RxDoctor Payments Data

Rushil Rao, MD

Retina Specialist · San Antonio, TXNPI 1518250398

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,294 of the $2,794 with a category attached, or 82.1%. It is spread thinly across 13 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $927 and has fallen 65.7% since, to $318 in 2025. That places this record below the midpoint for retina specialist clinicians in TX, where the typical reported total is $2,568.

$2,794in general payments, 2019–2025

Across 54 payments — averaging $51.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$535
  • Eyepoint US, Inc.$402
  • AbbVie$393
  • Alimera Sciences, Inc.$392
  • Genentech USA, Inc.$262
  • Dutch Ophthalmic, USA$216
  • plus $594 from 7 others

What the payments were for

  • Consulting fees$1505%
  • Speaking & faculty fees$35013%
  • Food & beverage$2,29482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,794 in reported general payments places this provider in the 50th percentile of 108 retina specialist providers in Texas.

See all retina specialist providers in Texas

Medicare billing

Part B allowed, 2024
$62,465
Medicare patients
157
Services billed
532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate14$737
MoxifloxacinMoxifloxacin Hcl14$383
Latanoprost29$139

Paid to pharmacies, not to this prescriber.

Other retina specialist in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →